Latest / Chip Stock Investor Podcast
TMDX Stock: Can Transmedics Maintain 30%+ Growth in 2026?
Transmedics (TMDX) finished a great fiscal year in2025, but the market is reacting to some interesting shifts in their 2026 guidance. In this video, we break down why this organ care leader is a small bet in the Chip Stock Investor portfolio and what the inflection point from operating loss to profit means for long-term holders.<br>In this video, we cover:--37% annual revenue growth and the Q4 beat.-- How sensors and semiconductor connectivity are replacing the ice chest legacy of organ transport.--Why Transmedics bought an aviation company and how their fleet of 22 aircraft is changing the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.